Share-based Compensation (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
Share-based Compensation |
|
Schedule of compensation expenses recognized for share based awards granted |
| | | | | | | Six Months Ended June 30, | | | 2024 | | 2025 | | | (Unaudited) | | (Unaudited) | Cost of sales | | 28,451 | | 27,868 | Research and development expenses | | 536,093 | | 569,667 | Selling, general and administrative expenses | | 227,620 | | 299,579 | Total | | 792,164 | | 897,114 |
|
Schedule of stock option activity |
| | | | | | | | | | | | | Weighted | | Weighted | | | | | Number of | | Average | | Average | | Aggregate | | | Options | | Exercise | | Remaining | | Intrinsic | | | Outstanding | | Price | | Contractual Life | | Value | | | | | US$ | | In Years | | US$ | Outstanding as of December 31, 2024 | | 52,060,649 | | 3.55 | | 2.60 | | 100,420 | Granted | | — | | — | | — | | — | Exercised | | (1,326,807) | | 1.80 | | — | | — | Cancelled | | (10,530) | | 43.19 | | — | | — | Expired | | (153,729) | | 12.83 | | — | | — | Outstanding as of June 30, 2025 (Unaudited) | | 50,569,583 | | 3.56 | | 2.06 | | 54,447 | | | | | | | | | | Vested and expected to vest as of June 30, 2025 (Unaudited) | | 50,495,087 | | 3.56 | | 2.07 | | 54,370 | Exercisable as of June 30, 2025 (Unaudited) | | 49,079,653 | | 3.59 | | 2.01 | | 52,901 |
|
Schedule of share options to employees |
| | | | | | | | | | | | | Weighted | | Weighted | | | | | Number of | | Average | | Average | | Aggregate | | | Options | | Exercise | | Remaining | | Intrinsic | | | Outstanding | | Price | | Contractual Life | | Value | | | | | US$ | | In Years | | US$ | Outstanding as of December 31, 2024 | | 43,094,529 | | 0.00001 | | 8.09 | | 47,950 | Granted | | — | | — | | — | | — | Exercised | | (6,954,456) | | — | | — | | — | Forfeited | | (1,449,661) | | — | | — | | — | Outstanding as of June 30, 2025 (Unaudited) | | 34,690,412 | | 0.00001 | | 7.70 | | 38,974 |
|
NIO Incentive Plans |
|
Share-based Compensation |
|
Schedule of weighted average assumptions used |
| | | | | | Six Months Ended June 30, | | | | 2024 | | | | (Unaudited) | | Exercise price (US$) | | 2.39 | | Fair value of the ordinary shares on the date of option grant (US$) | | 5.48 | | Risk-free interest rate | | 4.14 | % | Exercise multiple | | 2.5 | x | Expected dividend yield | | 0 | % | Expected volatility | | 62 | % | Expected forfeiture rate (post-vesting) | | 6.09 | % |
|
A Plan |
|
Share-based Compensation |
|
Schedule of weighted average assumptions used |
| | | | | | Six Months Ended June 30, | | | | 2024 | | | | (Unaudited) | | Fair value of the ordinary shares on the date of option grant (US$) | | 1.00-1.01 | | Risk-free interest rate | | 1.58 | % | Expected term (in years) | | 10 | | Expected dividend yield | | 0 | % | Expected volatility | | 52 | % | Expected forfeiture rate (post-vesting) | | 2 | % |
|
US employees under 2016 Plan | NIO Incentive Plans |
|
Share-based Compensation |
|
Schedule of restricted shares activity |
| | | | | | | Number of Restricted | | Weighted Average | | | Shares Outstanding | | Grant Date Fair Value | | | | | US$ | Unvested at December 31, 2024 | | 61,852,743 | | 10.96 | Granted | | 22,782,772 | | 3.82 | Vested | | (14,457,009) | | 10.35 | Forfeited | | (9,532,496) | | 9.52 | Unvested at June 30, 2025 (Unaudited) | | 60,646,010 | | 8.65 |
|